Emotion dysregulation is considered a transdiagnostic symptom and an underlying mechanism of psychopathology. It is present in patients with borderline personality disorder, complex PTSD, and ADHD, among others. While there are evidence-based behavioral interventions to improve emotion dysregulation, pharmacological strategies are less well studied. This Collection focuses on pharmacologic strategies for modulating emotion regulation. Clinical intervention studies are welcome, as are laboratory studies. We encourage submission of feasibility studies and confirmatory data on pharmacologic interventions that focus on emotion dysregulation, whether transdiagnostic or in specific clinical groups. In addition, research on basal mechanisms of emotion regulation that could serve as the basis for future pharmacological intervention strategies is welcome.
Edited by Stefan Röpke (email@example.com)